study involved patients aged 18 65 schizophrenia required treatment changes due insufficient response intolerability . Exclusions included hypersensitivity study drugs , acute suicidality , involuntary treatment , significant interactions antipsychotic treatment . Cannabis abuse exclusion criterion . Neuroleptic Strategy Study ( NeSSy ) included 136 patients 14 German psychiatric hospitals , comparing typical atypical antipsychotics . Patients provided informed consent randomized FGA SGA groups . However , 136 patients evaluated due dropouts non-compliance , 63 FGA group 73 SGA group . study used PSP questionnaire , assessing four dimensions functioning . Sociodemographic data collected 122 patients , baseline profiles age , sex , diagnosis , duration , severity depression . study design multicentre , double-blind , randomized trial , adhering ethical guidelines Good Clinical Practice . Medication involved FGAs SGAs 24 weeks , follow-up services offered . PSP scales assessed psychopathological symptoms , quality life , functional abilities . Data collected baseline visits 0 , 4 , 6 . Statistical analysis included imputation missing values correlation computations . primary efficacy analysis focused SF36 CGI values time .